Seeking Alpha
 

Aetna, Inc. (AET)

- NYSE
  • Dec. 30, 2012, 11:35 AM
    At $28K a vial, Questcor's (QCOR) Acthar has propelled shares to huge gains. QCOR bought the drug for $100K in 2001, planning to produce it only to treat infantile spasms. But thanks to aggressive marketing, it's now being prescribed for MS, arthritis, and kidney disease. Aetna's (AET) decision to limit off-label treatments has hit shares, but it's not clear any viable alternatives are on the horizon. (NYT)
    | 32 Comments
  • Dec. 12, 2012, 10:06 AM
    Aetna (AET), which is holding its investor day, joins United Health and Cigna in providing 2013 guidance that's below consensus. Aetna forecasts EPS of at least $5.40 vs consensus of $5.52 and revenue growth of 9% to $38.6B vs $38.91B. Predicts that commercial-medical costs will rise 6.5%, the same as this year. BMO analyst Dave Shove says the outlook reflects "management’s cautious stance on guiding high." Shares +4.2%.
    | Comment!
  • Dec. 7, 2012, 9:34 AM
    Aetna (AET +2.4%) settles for $120M (subject to judge's approval) a class action suit relating to payments of claims to Aetna members who were served by non-contracted health-care providers. In other news, the stock is upgraded to Overweight with $52 price target by JPMorgan.
    | Comment!
  • Dec. 6, 2012, 9:06 AM
    Aetna's (AET) cancer-management program, which it's carrying out with the U.S. Oncology Network and a McKesson (MCK) unit, had a positive impact on patients and helped to cut costs. The scheme cut ER visits 39.8%, hospital admissions 16.5% and the number of hospital days 35.9%. The scheme led to 12% cost savings among lung, breast and colorectal cancers alone. (PR)
    | 1 Comment
  • Nov. 30, 2012, 3:44 PM
    Aetna (AET) declares $0.20/share quarterly dividend, 14.3% increase from prior dividend of $0.175. Forward yield 1.87%. For shareholders of record Jan 10. Payable Jan 15. Ex-div date Jan 08. (PR)
    | Comment!
  • Nov. 30, 2012, 12:30 PM
    More on Questcor (QCOR -6.4%): Aetna's (AET +0.3%) latest bulletin shows no change from its position first taken in September on Acthar. The insurer is still limiting reimbursement of the drug only for the treatment of infantile spasms. AET asserts that the drug's other approved uses are medically unnecessary or unproven.
    | 2 Comments
  • Nov. 28, 2012, 5:56 AM
    Numerous CEOs of major companies are off to Washington today to talk to President Obama and/or John Boehner about averting the fiscal cliff. Those meeting Obama include the leaders of Merck (MRK), Coca-Cola (KO) and Caterpillar (CAT), while those meeting Boehner include the CEOs of Honeywell (HON) and Aetna (AET). Company bosses have also been urging their staff to pressure Washington to reach a deal.
    | 3 Comments
  • Nov. 21, 2012, 1:42 PM
    Aetna (AET +1.2%) releases a statement after Coventry Health Care (CVH +0.4%) stockholders voted overwhelmingly in favor of Aetna's proposed acquisition. AET CEO Mark Bertolini noted: “We continue to believe that Coventry will complement Aetna's strategy to expand our core insurance business, increase our presence in the fast-growing Government sector and expand our relationships with providers in local geographies.”
    | Comment!
  • Nov. 21, 2012, 10:40 AM
    Weight loss drug makers get a lift today after Aetna (AET -0.6%) revises its criteria under which the insurer considers weight reduction medications as "medically necessary" for treatment of obesity. In a Clinical Policy Bulletin revision dated yesterday, AET identified certain medications that have been approved by the FDA for weight reduction which would be covered under its policy: Qsymia, marketed by VIVUS (VVUS +13.2%), Belviq from Arena Pharmaceuticals (ARNA +2.9%), Didrex from Pfizer (PFE +0.1%), Xenical from Roche (RHHBY +0.3) and GlaxoSmithKline's (GSK +0.2%) Alli. Orexigen (OREX +6.5%), although not named in the bulletin, is also higher on the news.
    | 11 Comments
  • Nov. 20, 2012, 3:34 PM
    Coventry Health (CVH -0.1%) says it plans to hold a special shareholder meeting to consider and vote on proposal to adopt merging Jaguar Merger Subsidiary into Coventry with Coventry continuing as the surviving corporation. The meeting will be held in Nashville, Tennessee on November 21 at 10 am.
    | Comment!
  • Oct. 26, 2012, 6:35 AM
    Coventry Health Care (CVH): Q3 EPS of $0.78 beats by $0.05. Revenue of $3.46B (+16% Y/Y) misses by $40M. (PR)
    | Comment!
  • Oct. 26, 2012, 12:10 AM
    Notable earnings before Friday’s open: ACI, AON, ARLP, AXL, B, CMCSA, CVH, DAN, DLR, EGO, ERIC, GT, HMSY, IMGN, IPG, KKR, LM, LYB, MCO, MRK, OHI, OSK, QSII, TASR, TCB, VTR, WY
    | Comment!
  • Oct. 25, 2012, 5:30 PM
    Notable earnings before Friday’s open: ACI, AON, ARLP, AXL, B, CMCSA, CVH, DAN, DLR, EGO, ERIC, GT, HMSY, IMGN, IPG, KKR, LM, LYB, MCO, MRK, OHI, OSK, QSII, TASR, TCB, VTR, WY
    | Comment!
  • Oct. 25, 2012, 8:50 AM
    More on Aetna (AET) Q3: EPS benefits from heavy buybacks. Profit +1.8% to $499.2M. Earnings boosted by higher premiums, cost cuts and people continuing to avoid the doctor, with the percentage of premiums spent on medical care 80.7% vs 82.4% in Q2. Hits FY target for about 18.2M members, +149K from Q2. Ups FY operating EPS guidance to $5.10 from $5-$5.10 prior estimate and vs $5.08 consensus.
    | Comment!
  • Oct. 25, 2012, 6:01 AM
    Aetna (AET): Q3 EPS of $1.55 beats by $0.21. Revenue of $8.89B (+6% Y/Y) misses by $60M. (PR)
    | Comment!
  • Oct. 25, 2012, 12:05 AM
    Notable earnings before Thursday’s open: ABB, AET, AUO, AVT, AZN, BEN, BG, BIIB, CAB, CCE, CELG, CL, CME, CMS, CNX, COP, CRR, CS, CVE, D, DBD, DDD, DNKN, EQT, GG, GTI, HERO, HOT, HSY, IMAX, IP, JBLU, JNS, LINE, LKQ, MCK, MJN, MO, MYL, NBL, NOV, NS, NVS, NXPI, NYT, O, ORI, OXY, PCAR, PCP, PDS, PG, PHM, POT, PTEN, RCL, ROC, RTN, RYN, S, SHW, SPG, SWI, TKR, TSM, TZOO, UA, UAL, VLY, VPHM, XEL, ZMH
    | Comment!
Visit Seeking Alpha's
AET vs. ETF Alternatives
Company Description
Aetna Inc. is a health care benefit company, which offers traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans.
Sector: Healthcare
Country: United States